The NIH is running trials to assess therapies that might help combat long Covid. I guess Jake should tell the NIH they don't know what they are doing.
The National Institutes of Health said Monday it launched mid-stage clinical trials to test at least four treatments, including Pfizer’s antiviral Covid-19 pill Paxlovid, as potential therapies for long Covid.
The initial study is looking at 4 treatments but at least 7 more are being planned.
The NIH expects to launch additional clinical trials to test at least seven more treatments “in the coming months.”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.